JTFM,we continue to hold all our shares of ANIP. In light of your post, this material from Amarin should be viewed as well. AMRN is one of our heaviest investments in terms of shares held and current value. Our base for all shares held = $2.75. AMRN closed today = $13.60.
We were in Chicago to hear Dr. Bhatt present Reduce-It results, 11/10/2018.
We wish the risk from CVD(causation of more deaths than all cancers combined) to be minimized at a low cost. Altho' I would have qualified to be included in the Reduce-It trial, I did not apply in April 2013. Now I co-pay, off-label, $36/year for Vascepa:
News 
Market Data 
Discover 
